ANAGENICS LIMITED — Regulatory Filings 2017

Sep 24, 2017

==> picture [172 x 45] intentionally omitted <==

ASX ANNOUNCEMENT

CHANGE OF SHARE REGISTRY DETAILS

SYDNEY: Monday, 25 September 2017, Cellmid Limited (ASX: CDY) advises that as of Monday, 2 October 2017, the Company will change its provider for shareholder registry services from BoardRoom Pty Limited to Automic Registry Services (Automic).

Shareholders can easily and efficiently manage their holdings via Automic’s secure and highly accessible online investor portal. The portal provides, among other things, an online interface to update and manage shareholder details, view balances and transaction history.

Shareholders who are not already users of Automic’s investor portal may visit https://investor.automic.com.au and sign up to register their details using the two simple steps provided in the setup process after 2 October 2017.

Should shareholders have any queries in relation to their holding with Cellmid Limited they should contact Automic as follows:

Registered Address

Level 3 50 Holt Street Surry Hills NSW 2010 Telephone 1300 288 664 (within Australia) +61 2 9698 5414 (outside Australia) Email : hello@automic.com.au Investor portal : https://investor.automic.com.au/#/home

End Contact: Raymond Ting, Company Secretary T +612 9221 6830

Cellmid Limited (ASX: CDY)

Cellmid is an Australian life sciences company with lead programs in multiple disease indications. The Company, through its wholly owned subsidiaries, Lyramid, Kinera and Advangen, develops and markets innovative novel therapies and diagnostic tests for fibrotic diseases, cancer, ischemic diseases of the heart and hair loss. Cellmid holds the largest and most comprehensive portfolio of intellectual property relating to the novel targets midkine (MK) and FGF5 globally. Intellectual property pertaining midkine is being exploited through wholly owned subsidiaries Lyramid and Kinera. Advangen, Cellmid’s consumer health business, sells its FGF5 inhibitor hair growth products in Australia, Japan and the USA and currently expanding distribution in other territories. For further information, please see www.cellmid.com.au and www.evolisproducts.com.au.

CELLMID LIMITED ACN 111 304 119 ASX I CDY Suite 1802, Level 18, 15 Castlereagh Street, Sydney NSW 2000 AUSTRALIA TELEPHONE +61 2 9221 6830 FACSIMILE +61 2 9221 8535 WEB www.cellmid.com.au